Australia is carefully awaiting the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://jadafmjy278717.wikinarration.com/7922191/novo_nordisk_s_retatrutide_australia_a_new_solution_for_weight_management